Abstract
Mitochondrial diseases are commonly caused by mutated mitochondrial DNA (mtDNA), which in most cases coexists with wild-type mtDNA, resulting in mtDNA heteroplasmy. We have engineered transcription activator-like effector nucleases (TALENs) to localize to mitochondria and cleave different classes of pathogenic mtDNA mutations. Mitochondria-targeted TALEN (mitoTALEN) expression led to permanent reductions in deletion or point-mutant mtDNA in patient-derived cells, raising the possibility that these mitochondrial nucleases can be therapeutic for some mitochondrial diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Schon, E.A., DiMauro, S. & Hirano, M. Nat. Rev. Genet. 13, 878–890 (2012).
Vafai, S.B. & Mootha, V.K. Nature 491, 374–383 (2012).
Wallace, D.C. Environ. Mol. Mutagen. 51, 440–450 (2010).
Bacman, S.R., Williams, S.L., Garcia, S. & Moraes, C.T. Gene Ther. 17, 713–720 (2010).
Comte, C. et al. Nucleic Acids Res. 41, 418–433 (2013).
Taylor, R.W., Chinnery, P.F., Turnbull, D.M. & Lightowlers, R.N. Nat. Genet. 15, 212–215 (1997).
Minczuk, M., Papworth, M.A., Miller, J.C., Murphy, M.P. & Klug, A. Nucleic Acids Res. 36, 3926–3938 (2008).
Hockemeyer, D. et al. Nat. Biotechnol. 29, 731–734 (2011).
Sung, Y.H. et al. Nat. Biotechnol. 31, 23–24 (2013).
Schon, E.A. et al. Science 244, 346–349 (1989).
Corral-Debrinski, M. et al. Nat. Genet. 2, 324–329 (1992).
Soong, N.W., Hinton, D.R., Cortopassi, G. & Arnheim, N. Nat. Genet. 2, 318–323 (1992).
Diaz, F. et al. Nucleic Acids Res. 30, 4626–4633 (2002).
Jun, A.S., Trounce, I.A., Brown, M.D., Shoffner, J.M. & Wallace, D.C. Mol. Cell Biol. 16, 771–777 (1996).
Bacman, S.R., Williams, S.L., Duan, D. & Moraes, C.T. Gene Ther. 19, 1101–1106 (2012).
Carling, P.J., Cree, L.M. & Chinnery, P.F. Mitochondrion 11, 686–692 (2011).
Moraes, C.T. Trends Genet. 17, 199–205 (2001).
Szymczak, A.L. et al. Nat. Biotechnol. 22, 589–594 (2004).
Liddell, L., Manthey, G., Pannunzio, N. & Bailis, A. J. Vis. Exp. e3150 http://dx.doi.org/10.3791/3150 (2011).
King, M.P. & Attardi, G. Science 246, 500–503 (1989).
Sciacco, M., Bonilla, E., Schon, E.A., DiMauro, S. & Moraes, C.T. Hum. Mol. Genet. 3, 13–19 (1994).
Bacman, S.R. & Moraes, C.T. Methods Cell Biol. 80, 503–524 (2007).
Jun, A.S., Brown, M.D. & Wallace, D.C. Proc. Natl. Acad. Sci. USA 91, 6206–6210 (1994).
Bayona-Bafaluy, M.P., Blits, B., Battersby, B.J., Shoubridge, E.A. & Moraes, C.T. Proc. Natl. Acad. Sci. USA 102, 14392–14397 (2005).
Moraes, C.T., Ricci, E., Bonilla, E., DiMauro, S. & Schon, E.A. Am. J. Hum. Genet. 50, 934–949 (1992).
Martinez, B. et al. J. Neurochem. 78, 1054–1063 (2001).
Acknowledgements
This work was supported by US National Institutes of Health grants 5R01EY010804, 1R01AG036871 and 1R01NS079965, the Muscular Dystrophy Association and The JDM Fund. We thank M. Hirano (Columbia University) for the G14459A cells, F. Delacote (Cellectis bioresearch) for expert assistance in designing TALENs, G. Zhai for critically reading the manuscript and A. Pickrell for critical scientific suggestions.
Author information
Authors and Affiliations
Contributions
S.R.B. and S.L.W. designed and conducted most experiments and assisted in writing the manuscript. M.P. assisted in the quantification of mtDNA deletions and in writing the manuscript. S.P. conducted the complex I activity experiments and assisted in writing the manuscript. C.T.M. designed and supervised the project and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–6 and Supplementary Table 1 (PDF 12499 kb)
Rights and permissions
About this article
Cite this article
Bacman, S., Williams, S., Pinto, M. et al. Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs. Nat Med 19, 1111–1113 (2013). https://doi.org/10.1038/nm.3261
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3261
This article is cited by
-
TALE-based organellar genome editing and gene expression in plants
Plant Cell Reports (2024)
-
Effects of adverse fertility-related factors on mitochondrial DNA in the oocyte: a comprehensive review
Reproductive Biology and Endocrinology (2023)
-
Secondary structure of the human mitochondrial genome affects formation of deletions
BMC Biology (2023)
-
Correction of a homoplasmic mitochondrial tRNA mutation in patient-derived iPSCs via a mitochondrial base editor
Communications Biology (2023)
-
Efficient elimination of MELAS-associated m.3243G mutant mitochondrial DNA by an engineered mitoARCUS nuclease
Nature Metabolism (2023)